These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25028065)

  • 1. Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale.
    Keefe RS; Davis VG; Spagnola NB; Hilt D; Dgetluck N; Ruse S; Patterson TD; Narasimhan M; Harvey PD
    Eur Neuropsychopharmacol; 2015 Feb; 25(2):176-84. PubMed ID: 25028065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia.
    Keefe RS; Meltzer HA; Dgetluck N; Gawryl M; Koenig G; Moebius HJ; Lombardo I; Hilt DC
    Neuropsychopharmacology; 2015 Dec; 40(13):3053-60. PubMed ID: 26089183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interview-based assessment of cognition in schizophrenia: applicability of the Schizophrenia Cognition Rating Scale (SCoRS) in different phases of illness and settings of care.
    Vita A; Deste G; Barlati S; De Peri L; Giambra A; Poli R; Keefe RS; Sacchetti E
    Schizophr Res; 2013 May; 146(1-3):217-23. PubMed ID: 23510596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity.
    Keefe RS; Poe M; Walker TM; Kang JW; Harvey PD
    Am J Psychiatry; 2006 Mar; 163(3):426-32. PubMed ID: 16513863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.
    Harvey PD; Ogasa M; Cucchiaro J; Loebel A; Keefe RS
    Schizophr Res; 2011 Apr; 127(1-3):188-94. PubMed ID: 21277745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Persian version of the Schizophrenia Cognition Rating Scale (SCoRS) in patients with schizophrenia.
    Mazhari S; Ghafaree-Nejad AR; Soleymani-Zade S; Keefe RSE
    Asian J Psychiatr; 2017 Jun; 27():12-15. PubMed ID: 28558882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
    Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
    Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Schizophrenia Cognition Rating Scale: validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia.
    Chia MY; Chan WY; Chua KY; Lee H; Lee J; Lee R; Lim C; Tay E; Woon PS; Keefe RS; Sim K
    Psychiatry Res; 2010 Jun; 178(1):33-8. PubMed ID: 20451258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.
    Cruz BF; de Resende CB; Abreu MN; Rocha FL; Teixeira AL; Keefe RS; Salgado JV
    Cogn Neuropsychiatry; 2013 May; 18(3):243-51. PubMed ID: 23145794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cognitive Assessment Interview (CAI): reliability and validity of a brief interview-based measure of cognition.
    Ventura J; Reise SP; Keefe RS; Hurford IM; Wood RC; Bilder RM
    Schizophr Bull; 2013 May; 39(3):583-91. PubMed ID: 22328641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interview-based assessment of cognition is a strong predictor of quality of life in patients with schizophrenia and severe negative symptoms.
    Cruz BF; Resende CB; Carvalhaes CF; Cardoso CS; Teixeira AL; Keefe RS; Rocha FL; Salgado JV
    Braz J Psychiatry; 2016; 38(3):216-21. PubMed ID: 27304257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia.
    Reise SP; Ventura J; Keefe RS; Baade LE; Gold JM; Green MF; Kern RS; Mesholam-Gately R; Nuechterlein KH; Seidman LJ; Bilder R
    Psychol Assess; 2011 Mar; 23(1):245-61. PubMed ID: 21381848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia].
    Kaneda Y; Ueoka Y; Sumiyoshi T; Yasui-Furukori N; Ito T; Higuchi Y; Suzuki M; Ohmori T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Nov; 31(5-6):259-62. PubMed ID: 22256616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and psychometric performance of the schizophrenia objective functioning instrument: an interviewer administered measure of function.
    Kleinman L; Lieberman J; Dube S; Mohs R; Zhao Y; Kinon B; Carpenter W; Harvey PD; Green MF; Keefe RS; Frank L; Bowman L; Revicki DA
    Schizophr Res; 2009 Feb; 107(2-3):275-85. PubMed ID: 19013769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Korean Version of the Schizophrenia Cognition Rating Scale: Reliability and Validity.
    Kang EC; Kim SJ; Seo YS; Jung SS; Seo BJ; Ryu JW; Shim JC; Moon JJ; Jeon DW; Park KD; Jung DU
    Psychiatry Investig; 2017 Mar; 14(2):141-149. PubMed ID: 28326111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
    Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
    Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cognitive Assessment Interview (CAI): development and validation of an empirically derived, brief interview-based measure of cognition.
    Ventura J; Reise SP; Keefe RS; Baade LE; Gold JM; Green MF; Kern RS; Mesholam-Gately R; Nuechterlein KH; Seidman LJ; Bilder RM
    Schizophr Res; 2010 Aug; 121(1-3):24-31. PubMed ID: 20542412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of the accuracy of self assessment of everyday functioning in people with schizophrenia.
    Sabbag S; Twamley EW; Vella L; Heaton RK; Patterson TL; Harvey PD
    Schizophr Res; 2012 May; 137(1-3):190-5. PubMed ID: 22386735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive review of the research employing the schizophrenia cognition rating scale (SCoRS).
    Harvey PD; Khan A; Atkins A; Walker TM; Keefe RSE
    Schizophr Res; 2019 Aug; 210():30-38. PubMed ID: 31196736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between Performance-Based and Interview-Based Cognitive Measurements in Patients with Schizophrenia.
    Jeon DW; Jung DU; Oh M; Moon JJ; Kim SJ; Kim YS
    Psychiatry Investig; 2020 Jul; 17(7):695-701. PubMed ID: 32631031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.